Hunt Nimrata
SEC CIK 1800619 · EDGAR
BoughtSold
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-03 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale | $634.57 | -1,758 | 18.1K | -9% | -$1.12M | |
| 2026-02-27 | 2026-02-26 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale | $661.54 | -2,693 | 19.9K | -12% | -$1.78M | |
| D | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | F - Tax | $629.35 | -1,154 | 22.6K | -5% | -$726.3K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $0.00 | +2,587 | 21.6K | +14% | $0 |
| DM | 2025-11-10 | 2025-11-07 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale+OE | $703.34 | -9,425 | 25.5K | -27% | -$6.63M |
| DM | 2025-11-10 | 2025-11-07 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $382.28 | +12.5K | 30.6K | +69% | +$4.79M |
| DM | 2025-08-13 | 2025-08-12 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $244.16 | +1,226 | 17.8K | +7% | +$299.3K |
| D | 2025-08-13 | 2025-08-11 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale+OE | $656.53 | -1,200 | 16.8K | -7% | -$787.8K |
| DM | 2025-08-08 | 2025-08-06 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $187.57 | +12.8K | 25.1K | +104% | +$2.40M |
| DM | 2025-08-08 | 2025-08-06 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale+OE | $630.43 | -7,143 | 22.1K | -24% | -$4.50M |
| D | 2025-06-02 | 2025-06-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +343 | 4,202 | +9% | $0 |
| D | 2025-03-03 | 2025-03-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +342 | 3,859 | +10% | $0 |
| DM | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $0.00 | +872 | 12.1K | +8% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | F - Tax | $444.53 | -268 | 12.3K | -2% | -$119.1K |
| D | 2024-12-02 | 2024-12-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +343 | 3,517 | +11% | $0 |
| D | 2024-09-03 | 2024-09-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +343 | 3,174 | +12% | $0 |
| D | 2024-06-03 | 2024-06-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +302 | 2,831 | +12% | $0 |
| D | 2024-03-05 | 2024-03-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +302 | 2,529 | +14% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | A - Grant | $0.00 | +208 | 11.9K | +2% | $0 |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $0.00 | +664 | 11.2K | +6% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | F - Tax | $560.56 | -263 | 11.7K | -2% | -$147.4K |
| D | 2023-12-01 | 2023-12-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +303 | 2,227 | +16% | $0 |
| D | 2023-09-05 | 2023-09-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +302 | 1,924 | +19% | $0 |
| D | 2023-06-05 | 2023-06-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +300 | 1,622 | +23% | $0 |
| D | 2023-03-03 | 2023-03-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +299 | 1,322 | +29% | $0 |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $0.00 | +791 | 10.6K | +8% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | F - Tax | $503.65 | -239 | 11.0K | -2% | -$120.4K |
| D | 2023-02-10 | 2023-02-09 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $141.60 | +706 | 10.5K | +7% | +$100.0K |
| D | 2022-12-05 | 2022-12-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +300 | 1,023 | +41% | $0 |
| D | 2022-09-06 | 2022-09-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +300 | 723 | +71% | $0 |
| D | 2022-06-02 | 2022-06-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +254 | 423 | +150% | $0 |
| D | 2022-03-03 | 2022-03-01 | VEEV | Veeva Systems | Hunt Nimrata | Dir | M - OptEx | $0.00 | +169 | 169 | New | $0 |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $0.00 | +675 | 9,745 | +7% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | F - Tax | $505.53 | -204 | 9,702 | -2% | -$103.1K |
| DM | 2021-08-12 | 2021-08-10 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $90.32 | +1,106 | 9,212 | +14% | +$99.9K |
| DM | 2021-08-09 | 2021-08-05 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | M - OptEx | $137.90 | +538 | 8,644 | +7% | +$74.2K |
| D | 2021-08-09 | 2021-08-05 | IDXX | Idexx Laboratories | Hunt Nimrata | EVP | S - Sale+OE | $703.00 | -538 | 8,106 | -6% | -$378.2K |
Purchase Sale Sale after option exercise All abbreviations